Latest Insider Transactions at Brickell Biotech, Inc. (BBI)
This section provides a real-time view of insider transactions for Brickell Biotech, Inc. (BBI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Brickell Biotech, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Brickell Biotech, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2023
|
Andrew D Sklawer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+47.78%
|
-
|
|
Sep 01
2023
|
Deepak Chadha Former Chief R&D Officer & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,978
-40.16%
|
$0
$0.62 P/Share
|
|
Sep 01
2023
|
Deepak Chadha Former Chief R&D Officer & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+48.41%
|
-
|
|
Dec 31
2021
|
Reginald L Hardy CHAIRMAN OF THE BOARD |
SELL
Payment of exercise price or tax liability
|
Direct |
15,180
-3.39%
|
$0
$0.23 P/Share
|
|
Jul 26
2021
|
Reginald L Hardy CHAIRMAN OF THE BOARD |
BUY
Open market or private purchase
|
Direct |
100,000
+18.23%
|
$0
$0.67 P/Share
|
|
Jul 23
2021
|
David R. Mc Avoy Gen Counsel, CCO, & Secretary |
BUY
Open market or private purchase
|
Direct |
18,124
+12.33%
|
$0
$0.67 P/Share
|
|
Jul 23
2021
|
Reginald L Hardy CHAIRMAN OF THE BOARD |
BUY
Open market or private purchase
|
Direct |
100,000
+22.3%
|
$0
$0.66 P/Share
|
|
May 19
2021
|
Deepak Chadha Former Chief R&D Officer & COO |
BUY
Open market or private purchase
|
Direct |
12,500
+13.79%
|
$0
$0.83 P/Share
|
|
May 18
2021
|
Deepak Chadha Former Chief R&D Officer & COO |
BUY
Open market or private purchase
|
Direct |
2,700
+3.95%
|
$0
$0.82 P/Share
|
|
May 17
2021
|
David R. Mc Avoy Gen Counsel, CCO, & Secretary |
BUY
Open market or private purchase
|
Indirect |
7,980
+36.34%
|
$0
$0.8 P/Share
|
|
May 17
2021
|
David R. Mc Avoy Gen Counsel, CCO, & Secretary |
BUY
Open market or private purchase
|
Direct |
18,622
+14.39%
|
$0
$0.8 P/Share
|
|
May 17
2021
|
Andrew D Sklawer President and CEO |
BUY
Open market or private purchase
|
Direct |
15,375
+10.98%
|
$0
$0.8 P/Share
|
|
Mar 16
2021
|
Andrew D Sklawer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,000
-6.02%
|
$7,000
$1.14 P/Share
|
|
Mar 16
2021
|
Andrew D Sklawer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+14.68%
|
-
|
|
Mar 16
2021
|
David R. Mc Avoy Gen Counsel, CCO, & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
8,750
-8.67%
|
$8,750
$1.14 P/Share
|
|
Mar 16
2021
|
David R. Mc Avoy Gen Counsel, CCO, & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+19.86%
|
-
|
|
Mar 16
2021
|
Deepak Chadha Former Chief R&D Officer & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,750
-12.2%
|
$8,750
$1.14 P/Share
|
|
Mar 16
2021
|
Deepak Chadha Former Chief R&D Officer & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.85%
|
-
|
|
Mar 16
2021
|
Jose Breton Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,250
-30.58%
|
$5,250
$1.14 P/Share
|
|
Mar 16
2021
|
Jose Breton Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+46.63%
|
-
|
|
Mar 15
2021
|
Robert Busard Brown Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+34.85%
|
$100,000
$1.18 P/Share
|
|
Jan 01
2021
|
Reginald L Hardy CHAIRMAN OF THE BOARD |
BUY
Grant, award, or other acquisition
|
Direct |
47,435
+16.03%
|
$0
$0.78 P/Share
|
|
Dec 31
2020
|
Vijay B Samant Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,408
-18.72%
|
$0
$0.78 P/Share
|
|
Dec 31
2020
|
Gary A Lyons Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,967
-24.13%
|
$0
$0.78 P/Share
|
|
Dec 31
2020
|
Reginald L Hardy CHAIRMAN OF THE BOARD |
SELL
Payment of exercise price or tax liability
|
Direct |
4,873
-2.37%
|
$0
$0.78 P/Share
|
|
Jan 10
2019
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
0
|
-
|
|
Jan 10
2019
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,190,500
-50.24%
|
$0
$0.88 P/Share
|
|
Jun 28
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 28
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,276,591
+5.27%
|
$1,276,591
$1.2 P/Share
|
|
Jun 27
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 27
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
32,030
+0.34%
|
$32,030
$1.23 P/Share
|
|
Jun 26
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 26
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
9,103
+0.3%
|
$9,103
$1.24 P/Share
|
|
Jun 25
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 25
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,672
+0.35%
|
$10,672
$1.26 P/Share
|
|
Jun 22
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 22
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,520
+0.48%
|
$14,520
$1.25 P/Share
|
|
Jun 21
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 21
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
140
+0.0%
|
$140
$1.25 P/Share
|
|
Jun 20
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 20
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,702
+0.12%
|
$3,702
$1.27 P/Share
|
|
Jun 18
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 18
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
13,742
+0.45%
|
$13,742
$1.2 P/Share
|
|
Jun 14
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 14
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
29,103
+0.96%
|
$29,103
$1.15 P/Share
|
|
Jun 13
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 13
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
145,297
+4.66%
|
$145,297
$1.06 P/Share
|
|
Jun 12
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Jun 12
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
156,895
+2.69%
|
$156,895
$1.16 P/Share
|
|
Jun 11
2018
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|